Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | GRM8 | O00222 | 4/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 4/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | GRM6 | O15303 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | KMO | O15229 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6057603 | 0.98 | ACP3 (0.54) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL27462574 | 0.87 | ACP3 (0.52) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL7126589 | 0.87 | ALDH1A1 (0.56) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL6627469 | 0.85 | ALDH1A1 (0.54) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL5861774 | 0.83 | ACP3 (0.58) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL27780284 | 0.81 | ALDH1A1 (0.52) | ACP3TSHRLMNAALDH1A1HTT | |
| SCHEMBL11304497 | 0.81 | ACP3 (0.56) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL11057509 | 0.81 | ACP3 (0.56) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL5157317 | 0.81 | ACP3 (0.56) | ACP3TP53TSHRLMNAALDH1A1 | |
| SCHEMBL742437 | 0.81 | ACP3 (0.56) | ACP3TP53TSHRLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11012238-A | — | — | None | — | — | JP | disclosed |
| WO-2024125629-A1 | UREIC COMPOUND AND PHARMACEUTICAL USE THEREOF AS STING INHIBITOR | 中国药科大学 | 2024-06-20 | — | — | WO | disclosed |
| CN-117756698-A | Urea compound and medical application thereof as STING inhibitor | 中国药科大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-111440077-B | Synthesis method of 2, 5-diaminophenylethanol sulfate and application thereof in antiallergic hair dye | 上海舒尔发化妆品科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-111440077-A | Synthesis method of 2, 5-diaminophenylethanol sulfate and application thereof in anti-allergic hair dye | 上海舒尔发化妆品科技有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-103242177-A | Preparation method of 2,5-diaminophenethyl alcohol sulfate | UNIV ZHEJIANG TECHNOLOGY | 2013-08-14 | — | — | CN | disclosed |
| CN-101698647-B | Synthesis method of 2,5-diamino benzene ethanol | YIXING XINYU CHEMICAL CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-101717342-A | Method for synthesizing 2,5-diamino phenyl ethanol | CHIZHOU FANGDA SCIENCE & TECHN | 2010-06-02 | — | — | CN | disclosed |
| CN-101698647-A | Synthesis method of 2,5-diamino benzene ethanol | YIXING XINYU CHEMICAL CO LTD | 2010-04-28 | — | — | CN | disclosed |
| US-7449582-B2 | Compounds and compositions as protein kinase inhibitors | IRM LLC (BM) | 2008-11-11 | — | — | US | disclosed |
| EP-1673343-A4 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2008-09-10 | — | — | EP | disclosed |
| EP-1673343-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2006-06-28 | — | — | EP | disclosed |
| US-20050187230-A1 | Compounds and compositions as protein kinase inhibitors | IRM LLC (BM) | 2005-08-25 | — | — | US | disclosed |
| WO-2005034869-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2005-04-21 | — | — | WO | disclosed |
| JP-H1112238-A | PRODUCTION OF 1-(BETA-HYDROXYETHYL)-2,5-DIAMINOBENZENE OR ITS SALT | KAO CORP | 1999-01-19 | — | — | JP | disclosed |
| US-4771062-A | ENZYME INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187230-A1 | Compounds and compositions as protein kinase inhibitors | FYN, LCK, SRC | ACP3 2527/4885TP53 890/4885TSHR 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.